Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Filings indexed 684 across all filing types
Latest filing 2021-03-19 Capital/Financing Update
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '전환사채권 발행결정' (Decision to Issue Convertible Bonds) and '정정신고(보고)' (Correction Report). It details the issuance of convertible bonds, including terms like interest rates, conversion prices, put/call options, and the use of proceeds. This is a standard corporate finance disclosure regarding capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2021-03-19 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, put/call options, and the list of investors. This falls under the category of capital and financing updates.
2021-03-18 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, put/call options, and the use of proceeds. This falls under the category of capital and financing updates for a company.
2021-03-18 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a paid-in capital increase (유상증자결정) by PCL Inc. This is a formal regulatory filing submitted to the Financial Supervisory Service/Korea Exchange. It details the issuance of new shares, the purpose of the capital raise, and the third-party allocation details. Since it involves a change in capital structure through a share issuance, it falls under the 'Share Issue/Capital Change' category.
2021-03-18 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by PCL. It details the contract value, counterparty relationship, and terms. Since this is a specific regulatory disclosure of a business event that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2021-03-18 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by PCL. It details the contract value, counterparty relationship, and terms. Since this is a specific regulatory announcement of a material business event that does not fit into categories like financial reports, dividends, or share transactions, it falls under the general regulatory filing category.
2021-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.